Discover the new Chem-Impex: Where innovation starts with a bond.

Catalog Number:
37938
CAS Number:
65646-68-6
todo- trans -N-(4-Hidroxifenil)retinamida
Purity:
≥ 98 % (HPLC)
Synonym(s):
4-HPR, Ácido retinoico p -hidroxianilida
Documents
$160.34 /10 mg
Tamaño
Request Bulk Quote
Product Information

Conservar bajo gas inerte.

Synonyms
4-HPR, Ácido retinoico p -hidroxianilida
CAS Number
65646-68-6
Purity
≥ 98 % (HPLC)
Molecular Formula
C26H33NO2
Molecular Weight
391.56
MDL Number
MFCD00792674
PubChem ID
1744
Melting Point
170 - 174 ?C
Appearance
Polvo de color blanco a amarillo a naranja hasta cristal.
Conditions
Conservar a < -20 °C
General Information
Synonyms
4-HPR, Ácido retinoico p -hidroxianilida
CAS Number
65646-68-6
Purity
≥ 98 % (HPLC)
Molecular Formula
C26H33NO2
Molecular Weight
391.56
MDL Number
MFCD00792674
PubChem ID
1744
Melting Point
170 - 174 ?C
Appearance
Polvo de color blanco a amarillo a naranja hasta cristal.
Conditions
Conservar a < -20 °C
Properties
Additional property information coming soon!
-
Safety and Regulations
Hazmat
No
Antibiotic
No
DEA-regulated
No
Warnings
-
Applications

All-trans-N-(4-Hydroxyphenyl)retinamide is widely utilized in research focused on:

  • Dermatology: This compound is used in topical formulations for treating acne and photoaging due to its ability to regulate skin cell turnover and reduce inflammation.
  • Oncology: It has shown potential in cancer research, particularly in promoting apoptosis in certain cancer cells, making it a candidate for developing novel cancer therapies.
  • Ophthalmology: The compound is being studied for its protective effects on retinal cells, potentially aiding in the treatment of age-related macular degeneration and other retinal diseases.
  • Cosmetics: Its antioxidant properties make it a valuable ingredient in anti-aging products, helping to improve skin texture and reduce the appearance of fine lines.
  • Pharmaceuticals: The compound is explored for its role in modulating gene expression, which can lead to advancements in drug development for various diseases, including neurodegenerative disorders.

Citas